Patent Assignment
Reel/Frame 060781/0230
Change of Name
Recorded: 2022-08-11
Pages: 6
Assignor
DMNOMORE LIMITED
Executed: 2020-03-13
Assignee
PHAIM PHARMA LTD
ONE BARTHOLOMEW CLOSE, LONDON, EC1A 7BL, UNITED KINGDOM
Covered Property
(1)
CTLA4 Fusion Proteins for the Treatment of Diabetes
Application:
14/021,629 →
Publication:
US 2014/0099306
Related Assignments
(2)
Other recorded transfers of the patent in this record — the chain of ownership.